Free Trial

Encompass Health (EHC) Earnings Date, Estimates & Call Transcripts

Encompass Health logo
$113.33 +11.92 (+11.75%)
Closing price 04/25/2025 03:59 PM Eastern
Extended Trading
$113.09 -0.24 (-0.21%)
As of 04/25/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Encompass Health Earnings Summary

Latest Q1
Earnings Date
Apr. 24Estimated
Consensus EPS
(Apr. 24)
$1.19
Actual EPS
(Apr. 24)
$1.37 Beat By $0.18
Actual Revenue
(Apr. 24)
$1.46B

Encompass Health announced Q1 2025 earnings on April 24, 2025, reporting an EPS of $1.37, which beat the consensus estimate of $1.19 by $0.18. Quarterly revenue was reported to be $1.46 billion, above analysts' expectations of $1.43 billion. With a trailing EPS of $4.46 and a P/E Ratio of 25.41, Encompass Health's earnings are expected to grow 10.00% next year, from $4.80 to $5.28 per share.

Get Encompass Health Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Encompass Health and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

EHC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

EHC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Encompass Health Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20253$1.16$1.26$1.20 
Q2 20253$1.12$1.18$1.15 
Q3 20253$1.13$1.15$1.14 
Q4 20253$1.14$1.32$1.25 
FY 202512$4.55$4.91$4.75 
Q1 20262$1.29$1.30$1.30 
Q2 20262$1.20$1.36$1.28 
Q3 20262$1.17$1.21$1.19 
Q4 20262$1.30$1.34$1.32 
FY 20268$4.96$5.21 $5.09

Encompass Health Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
4/24/2025Q1 2025$1.19$1.37+$0.18$1.48$1.43B$1.46B
2/6/2025Q4 2024$1.05$1.17+$0.12$1.18$1.38B-
10/28/2024Q3 2024$0.94$1.03+$0.09$1.00$1.33B$1.35B
8/5/2024Q2 2024$1.01$1.11+$0.10$1.10$1.30B$1.30B
4/24/2024Q1 2024$0.93$1.12+$0.19$1.14$1.27B$1.32B
2/7/2024Q4 2023$0.83$0.95+$0.12$1.04$1.24B$1.25B
10/27/2023Q3 2023$0.77$0.86+$0.09$0.88$1.19B$1.21B
8/1/2023Q2 2023$0.74$0.95+$0.21$1.00$1.16B$1.19B
4/28/2023Q1 2023$0.70$0.88+$0.18$0.89$1.14B$1.16B

Encompass Health Earnings - Frequently Asked Questions

Encompass Health (NYSE:EHC) last announced its quarterly earning data on Thursday, April 24, 2025. Learn more on EHC's earnings history.

Encompass Health issued an update on its FY 2025 earnings guidance on Thursday, April, 24th. The company provided earnings per share (EPS) guidance of 4.850-5.100 for the period, compared to the consensus estimate of 4.810. The company issued revenue guidance of $5.9 billion-$5.9 billion, compared to the consensus revenue estimate of $5.9 billion.

In the previous quarter, Encompass Health (NYSE:EHC) reported $1.37 earnings per share (EPS) to beat the analysts' consensus estimate of $1.19 by $0.18. Learn more on analysts' earnings estimate vs. EHC's actual earnings.

The conference call for Encompass Health's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Encompass Health's latest earnings report can be read online.
Read Transcript

Encompass Health (NYSE:EHC) has a recorded annual revenue of $5.37 billion.

Encompass Health (NYSE:EHC) has a recorded net income of $455.70 million. EHC has generated $4.46 earnings per share over the last four quarters.

Encompass Health (NYSE:EHC) has a trailing price-to-earnings ratio of 25.41 and a forward price-to-earnings ratio of 23.61. The price/earnings-to-growth ratio is 2.31.

Encompass Health's earnings are expected to grow from $4.80 per share to $5.28 per share in the next year, which is a 10.00% increase.

More Earnings Resources from MarketBeat



This page (NYSE:EHC) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners